Invasive Brain Monitoring Device Sales

Invasive Brain Monitoring Device Sales Market Outlook

The global Invasive Brain Monitoring Device Sales market is anticipated to reach USD 3.5 billion by 2033, growing at a CAGR of 6.2% from 2025 to 2033. This growth is largely attributed to the increasing prevalence of neurological disorders, the rising demand for effective brain monitoring solutions in critical care settings, and advancements in medical technology that enhance the effectiveness and reliability of monitoring devices. Moreover, the growing geriatric population, which is more susceptible to conditions requiring invasive brain monitoring, is expected to drive market expansion. The surge in trauma cases and improvements in healthcare infrastructure, particularly in emerging economies, are additional significant factors fueling market growth.

Growth Factor of the Market

The Invasive Brain Monitoring Device Sales market is experiencing substantial growth due to several driving factors. Primarily, the increasing incidence of traumatic brain injuries (TBI) and stroke cases necessitates advanced monitoring solutions to ensure patient safety and improve outcomes. Additionally, the rapid advancements in technology, such as miniaturization and wireless capabilities in monitoring devices, are unlocking new opportunities for more effective and less intrusive applications. Healthcare facilities are increasingly investing in state-of-the-art monitoring systems to enhance patient management protocols and improve clinical decision-making. Furthermore, the rise of telemedicine and remote patient monitoring is creating new avenues for the deployment of invasive brain monitoring devices, enabling healthcare providers to monitor patients more efficiently and address complications proactively. Increased awareness and education about neurological disorders among both clinicians and patients are also contributing to market dynamics, underscoring the importance of timely and effective interventions.

Key Highlights of the Market

• The market is experiencing robust growth due to technological advancements and increased prevalence of neurological conditions.
• North America holds the largest market share, driven by a well-established healthcare infrastructure and high adoption of advanced monitoring devices.
• Intracranial Pressure Monitors are witnessing significant demand owing to their critical role in managing severe brain conditions.
• There is a notable shift towards portable monitoring devices, enhancing patient comfort and allowing for greater mobility.
• Collaborations and partnerships among key industry players are becoming increasingly common to drive innovation and expand market reach.

By Product Type

Intracranial Pressure Monitors:

Intracranial Pressure (ICP) monitors are integral in the assessment of patients with severe head injuries or neurological diseases. They measure the pressure inside the skull, which can indicate the severity of brain injuries or conditions such as hydrocephalus. The rising prevalence of traumatic brain injuries and strokes globally is significantly propelling the demand for ICP monitoring devices. Additionally, advancements in technology have led to the development of more accurate and reliable ICP monitors, which are essential for providing real-time data to clinicians. This capability not only aids in immediate decision-making but also enhances long-term patient management strategies. As a result, the ICP monitors segment is expected to witness significant growth throughout the forecast period, contributing notably to the overall market dynamics.

Electroencephalography Devices:

Electroencephalography (EEG) devices are pivotal for monitoring electrical activity in the brain, particularly in diagnosing conditions such as epilepsy and sleep disorders. As the awareness and diagnosis of neurological conditions increase, the demand for EEG devices is also expected to rise. The integration of advanced technologies, such as wireless EEG and portable devices, enhances the usability and comfort for patients while allowing for greater flexibility in monitoring settings. The rise in the elderly population, who are more prone to neurological disorders, further fuels this segment's growth. Moreover, the trend towards outpatient and home healthcare solutions is promoting the adoption of EEG devices, as they can be utilized in various healthcare environments, from hospitals to patients' homes.

Microdialysis Devices:

Microdialysis devices play a crucial role in monitoring the chemical composition of the brain's extracellular fluid, providing insights into metabolic changes in critically ill patients. This segment is gaining traction as healthcare professionals increasingly recognize the importance of metabolic monitoring in real-time. The devices enable the continuous assessment of brain metabolism, which is vital for managing conditions like traumatic brain injury and cerebral ischemia. The technological advancements in microdialysis systems, including miniaturization and enhanced accuracy, are propelling their adoption in clinical settings. As research continues to unveil the importance of metabolic monitoring in patient outcomes, the microdialysis devices segment is poised for substantial growth in the coming years.

Brain Tissue Oxygen Monitors:

Brain Tissue Oxygen (PbtO2) monitors are specialized devices used to measure the oxygen levels in brain tissue, effectively guiding therapeutic interventions. With the increasing recognition of the critical role of oxygenation in brain injury management, the demand for PbtO2 monitors is on the rise. These devices provide essential information that aids clinicians in making timely decisions to prevent secondary brain injuries. The growing incidence of severe neurological conditions and advancements in monitoring technology are driving market growth in this segment. Furthermore, the ongoing research into better monitoring methods enhances the clinical efficacy of PbtO2 devices, thereby contributing to their market potential.

Others:

This category includes various emerging monitoring technologies that do not fit into the traditional segments. These devices are often in the developmental stages, focusing on innovative approaches to brain monitoring. As research and development efforts intensify, this segment is expected to gain significant traction, driven by the need for more advanced and personalized brain monitoring solutions. Innovations such as brain-computer interfaces and advanced imaging techniques are paving the way for new products that can enhance clinical outcomes. Overall, the "Others" segment indicates a growing interest in diversified monitoring technologies, which may reshape the market landscape in the years to come.

By Application

Traumatic Brain Injury:

Traumatic Brain Injury (TBI) represents one of the most significant applications for invasive brain monitoring devices, as timely and precise monitoring is crucial for patient management. The increasing incidence of TBIs due to vehicular accidents, sports injuries, and falls drives demand for these monitoring solutions. Advanced monitoring technologies, such as ICP monitors and EEG devices, play a vital role in diagnosing and managing TBIs, providing vital data to clinicians to inform treatment plans. The growing awareness about the long-term effects of TBIs, including cognitive impairment and psychological issues, has underscored the necessity for effective monitoring strategies, thus enhancing the market potential for this application segment.

Stroke:

Stroke is another critical application area for invasive brain monitoring devices, as timely intervention can significantly affect patient outcomes. The growing global prevalence of stroke, coupled with an aging population, is driving market growth. Monitoring devices are essential to assess brain activity and oxygenation levels during and after a stroke event. Technologies like PbtO2 monitoring and ICP monitoring enable healthcare providers to make informed decisions about patient care promptly. As the medical community continues to advance treatment protocols for stroke, the importance of real-time monitoring will further solidify the role of invasive brain monitoring devices in this application area.

Epilepsy:

Invasive monitoring devices are gaining increased importance in the management of epilepsy, particularly in refractory cases where traditional treatments fail. The ability to continuously monitor brain activity helps identify seizure patterns and potential triggers, leading to more tailored treatment plans. Devices such as EEG monitors are instrumental in diagnosing and managing epilepsy, facilitating timely interventions and improving patient quality of life. The growing awareness and diagnosis of epilepsy, alongside advancements in brain monitoring technologies, are expected to drive the demand for these devices in the epilepsy application segment significantly. As more patients seek effective management strategies, the market potential in this area remains high.

Others:

This segment encompasses additional applications of invasive brain monitoring devices, including research purposes and less common neurological conditions. Innovations in monitoring technology are leading to new applications that extend beyond traditional uses, facilitating ongoing research and development in neurophysiology. As healthcare providers become more aware of the broad spectrum of neurological disorders, the demand for versatile monitoring solutions is expected to increase. The potential for these devices to provide valuable data for understanding complex brain functions and disorders can drive growth in this application segment as research initiatives expand.

By End User

Hospitals:

Hospitals account for the largest share of the invasive brain monitoring device sales market. The critical care units within hospitals require efficient monitoring solutions for patients with severe neurological conditions, making these facilities primary users of sophisticated monitoring technologies. The increased number of hospital admissions due to neurological disorders and trauma cases necessitates the use of advanced devices to ensure patient safety and effective management. Moreover, hospitals are equipped with the resources to implement the latest technologies, enhancing their ability to provide real-time monitoring and intervention. As healthcare systems continue to evolve, hospitals will remain at the forefront of utilizing invasive brain monitoring devices.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are emerging as significant end users of invasive brain monitoring devices. The trend towards outpatient procedures and minimally invasive surgeries is fostering the growth of ASCs, which require effective monitoring solutions to ensure patient safety during and after procedures. The integration of advanced devices in these settings allows for closer monitoring of patients, enabling timely responses to complications. The growing acceptance of outpatient neurosurgical procedures further enhances the demand for brain monitoring technologies in ASCs. As healthcare shifts towards more decentralized models, the role of ASCs in utilizing invasive brain monitoring devices is expected to expand considerably.

Specialty Clinics:

Specialty clinics, particularly those focused on neurology and neurosurgery, are increasingly adopting invasive brain monitoring devices. These clinics require advanced monitoring solutions to manage specific neurological disorders effectively. The rise in patient referrals for specialized care is driving the demand for advanced monitoring technologies that provide accurate and timely data during treatment. Furthermore, the growing trend toward personalized medicine is pushing specialty clinics to adopt innovative monitoring solutions that help tailor interventions to individual patient needs. As the importance of neurological health continues to gain traction, specialty clinics will play a crucial role in the growth of the invasive brain monitoring device market.

Others:

The "Others" category includes various healthcare facilities and research institutions not classified under the primary end users. This segment may encompass research laboratories focusing on neurological studies and rehabilitation centers employing invasive monitoring devices for diverse patient needs. The ongoing research into neurological disorders is driving demand within this segment, as innovative monitoring technologies can enhance clinical insights and foster advancements in treatment protocols. Furthermore, as healthcare continues to innovate, this segment could see significant growth driven by the need for advanced monitoring solutions in various clinical and research settings.

By Modality

Portable Monitoring Devices:

Portable monitoring devices are revolutionizing the way brain monitoring is conducted in both clinical and non-clinical settings. The demand for mobility and ease of use is driving the adoption of these devices, offering clinicians the flexibility to monitor patients without being confined to traditional hospital settings. Portable monitoring solutions are particularly important in emergency situations, where real-time data can drastically affect patient outcomes. Moreover, advancements in battery technology and miniaturization have paved the way for the development of sophisticated portable devices that maintain high levels of accuracy and reliability. As healthcare shifts towards home care and outpatient services, the portable monitoring devices segment is expected to witness substantial growth.

Standalone Monitoring Devices:

Standalone monitoring devices continue to hold a significant share of the market, especially in critical care environments such as intensive care units (ICUs). These devices are designed to operate independently, providing essential monitoring functions without reliance on additional equipment. The reliability and precision of standalone devices make them indispensable in managing severe neurological conditions. As hospitals seek to enhance patient monitoring capabilities, standalone devices will remain a critical aspect of clinical practice. Furthermore, ongoing advancements in technology are leading to the development of next-generation standalone devices with improved features, further driving their adoption in healthcare settings.

By Region

The North American region dominates the invasive brain monitoring device sales market, accounting for approximately 45% of the total market share. The region’s well-established healthcare infrastructure, combined with a high level of technological adoption, drives demand for advanced monitoring solutions. Additionally, the increasing incidence of neurological disorders and traumatic brain injuries, alongside a growing aging population, is expected to further fuel market growth. The North American market is projected to experience a CAGR of 6.5% during the forecast period, highlighting its robust potential as a key player in the invasive brain monitoring device landscape.

In Europe, the invasive brain monitoring device market is also witnessing significant growth, driven by increasing investments in healthcare technologies and rising awareness regarding neurological disorders. The European market is characterized by a diversified landscape, with key players collaborating to enhance their product offerings and expand their market reach. The growing demand for innovative monitoring solutions in countries such as Germany, France, and the UK is contributing to the overall growth of the market in this region. Asia Pacific is anticipated to experience the fastest growth over the forecast period, attributed to rising healthcare expenditures, advancements in medical infrastructure, and an increasing prevalence of neurological diseases.

Opportunities

The Invasive Brain Monitoring Device Sales market is brimming with opportunities for growth and innovation. One of the most significant opportunities lies in the development of next-generation monitoring technologies that combine multiple functionalities into a single device, allowing for comprehensive patient monitoring. The integration of artificial intelligence and machine learning into brain monitoring devices can enhance data analysis and predictive capabilities, enabling healthcare providers to make informed decisions more efficiently. Furthermore, the rising trend of telemedicine creates a fertile ground for the adoption of remote monitoring solutions, allowing patients to receive care in the comfort of their homes while ensuring continuous oversight from healthcare professionals. As healthcare systems worldwide strive for improved patient outcomes and cost-effectiveness, the demand for innovative and adaptable invasive brain monitoring devices is expected to rise considerably in the coming years.

Another promising opportunity lies in expanding into emerging markets, where healthcare infrastructure is rapidly evolving. Regions such as Asia Pacific and Latin America present significant growth potential, driven by increasing investments in healthcare facilities, rising awareness about neurological disorders, and the need for advanced monitoring solutions. Collaborations and partnerships among manufacturers, healthcare providers, and research institutions can facilitate the introduction of new technologies into these markets, enhancing accessibility and affordability. Additionally, educating healthcare professionals about the benefits and applications of invasive brain monitoring devices can help bridge the gap between traditional practices and modern innovations, further driving market growth.

Threats

Despite the promising growth prospects for the Invasive Brain Monitoring Device Sales market, several threats could hinder its development. One of the primary challenges is the stringent regulatory landscape governing medical devices, which can complicate the approval process and delay the introduction of new products to market. Manufacturers must navigate complex regulatory requirements and ensure compliance with safety standards, which can pose significant hurdles, especially for smaller companies with limited resources. Moreover, the rapid pace of technological advancements means that companies must continually innovate to stay competitive, leading to increased research and development costs. Additionally, the threat of economic downturns or healthcare budget cuts may result in reduced spending on advanced monitoring technologies, impacting the overall market.

Another potential threat is the rising prevalence of data privacy concerns associated with the use of invasive monitoring devices, particularly those that utilize telemedicine or remote monitoring capabilities. As patients become more aware of their privacy rights, companies must ensure that their devices comply with data protection regulations and protect sensitive patient information. Failure to address these concerns could result in a loss of consumer trust and confidence, ultimately affecting market growth. Furthermore, the competitive landscape is becoming increasingly crowded as new players enter the market, resulting in pricing pressures that may impact profit margins for established companies. Overall, addressing these threats effectively will be crucial for sustained growth in the invasive brain monitoring device sales market.

Competitor Outlook

• Medtronic
• NeuroWave Systems, Inc.
• Integra LifeSciences
• Natus Medical Incorporated
• Raumedic AG
• Codman & Shurtleff, Inc.
• EDAP TMS S.A.
• Olympus Corporation
• Philips Healthcare
• Siemens Healthineers
• Edwards Lifesciences Corporation
• GE Healthcare
• Drägerwerk AG & Co. KGaA
• Cerebrotech Medical Systems, Inc.
• BrainScope Company, Inc.
• Blackrock Neurotech

The competitive landscape of the Invasive Brain Monitoring Device Sales market is characterized by the presence of various key players striving to innovate and expand their product offerings. Companies are focusing on strategic collaborations, partnerships, and mergers and acquisitions to enhance their technological capabilities and gain a competitive edge in the market. Additionally, ongoing research and development efforts are pivotal for companies looking to introduce advanced monitoring solutions that meet the evolving needs of healthcare providers and patients. The emphasis on improving patient outcomes and ensuring clinical effectiveness is central to the competitive strategies of these firms, as they aim to establish themselves as leaders in a rapidly changing healthcare environment.

Medtronic, a leading player in the market, offers a comprehensive range of invasive brain monitoring devices, including ICP monitors and neurostimulation systems. The company’s commitment to innovation and research has positioned it as a trusted provider in the field of neurological monitoring. Natus Medical Incorporated is another prominent player, known for its advanced EEG monitoring systems and neuromonitoring solutions tailored for critical care settings. The company focuses on expanding its portfolio through strategic acquisitions and collaborations to enhance its market presence and technological offerings. Similarly, Integra LifeSciences has a strong focus on invasive monitoring technologies, providing a wide range of products designed to address the specific needs of healthcare professionals managing neurological conditions.

As the market evolves, smaller players like NeuroWave Systems, Inc. and Cerebrotech Medical Systems, Inc. are gaining traction by focusing on niche segments and innovative technologies. These companies leverage their agility and specialization to develop cutting-edge monitoring devices that cater to specific patient populations or clinical needs. Additionally, companies like Philips Healthcare and Siemens Healthineers are capitalizing on their extensive experience in medical imaging and monitoring technologies, integrating their expertise to offer comprehensive brain monitoring solutions. The competitive dynamics of the invasive brain monitoring device sales market are expected to intensify as companies continue to invest in research and development, aiming to deliver innovative solutions that improve patient care and clinical outcomes.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Raumedic AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 EDAP TMS S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Philips Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Blackrock Neurotech
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Olympus Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Integra LifeSciences
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 NeuroWave Systems, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 BrainScope Company, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Codman & Shurtleff, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Natus Medical Incorporated
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Drägerwerk AG & Co. KGaA
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Edwards Lifesciences Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis
  • 5.16 Cerebrotech Medical Systems, Inc.
    • 5.16.1 Business Overview
    • 5.16.2 Products & Services
    • 5.16.3 Financials
    • 5.16.4 Recent Developments
    • 5.16.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Invasive Brain Monitoring Device Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Invasive Brain Monitoring Device Sales Market, By Modality
    • 6.2.1 Portable Monitoring Devices
    • 6.2.2 Standalone Monitoring Devices
  • 6.3 Invasive Brain Monitoring Device Sales Market, By Application
    • 6.3.1 Traumatic Brain Injury
    • 6.3.2 Stroke
    • 6.3.3 Epilepsy
    • 6.3.4 Others
  • 6.4 Invasive Brain Monitoring Device Sales Market, By Product Type
    • 6.4.1 Intracranial Pressure Monitors
    • 6.4.2 Electroencephalography Devices
    • 6.4.3 Microdialysis Devices
    • 6.4.4 Brain Tissue Oxygen Monitors
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Invasive Brain Monitoring Device Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Invasive Brain Monitoring Device Sales market is categorized based on

By Product Type

• Intracranial Pressure Monitors
• Electroencephalography Devices
• Microdialysis Devices
• Brain Tissue Oxygen Monitors
• Others

By Application

• Traumatic Brain Injury
• Stroke
• Epilepsy
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Modality

• Portable Monitoring Devices
• Standalone Monitoring Devices

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• NeuroWave Systems, Inc.
• Integra LifeSciences
• Natus Medical Incorporated
• Raumedic AG
• Codman & Shurtleff, Inc.
• EDAP TMS S.A.
• Olympus Corporation
• Philips Healthcare
• Siemens Healthineers
• Edwards Lifesciences Corporation
• GE Healthcare
• Drägerwerk AG & Co. KGaA
• Cerebrotech Medical Systems, Inc.
• BrainScope Company, Inc.
• Blackrock Neurotech